by HBOT News | Oct 9, 2010 | Macular Degeneration
Abstract: Worth, Carver, , , , , , , (). Age-related macular degeneration and hyperbaric oxygen. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, ;37(5):375; author reply...
by HBOT News | May 14, 2010 | Macular Degeneration
Abstract: Age-related macular degeneration (AMD) is a significant cause of visual loss in the United States and Western Europe. As the population ages, the prevalence rate of advanced AMD is expected to double by 2030. A one-hour session of hyperbaric oxygen therapy...
by HBOT News | Sep 20, 2007 | Macular Degeneration
Abstract: Macular edema was first described more than a century ago, and its medical treatment has made great progress thanks to recent pharmacological advances. Administration is topical, local (peri- or intraocular), or systemic. Nonsteroidal anti-inflammatory...
by HBOT News | Dec 30, 2019
International Indications Hyperbaric Oxygen Therapy has been used for the better part of two centuries. Globally, HBOT is used to extend life by augmenting the treatment of over 100 indications. Hyperbaric Oxygen Therapy involves breathing 100% oxygen in a pressurized...
by HBOT News | Oct 18, 2016 | Macular Degeneration
Abstract: To report on a case of autoconjunctival graft compromise after pterygium surgery in a patient on long-term anti-vascular endothelial growth factor (anti-VEGF) therapy, due to the deleterious effects of anti-VEGF agents on ocular wound healing. A white female...
